BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 43289)

  • 1. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonizing effect of normal cerebrospinal fluid on Staphylococcus aureus.
    Hou SC; Ho ST; Shaio MF
    J Formos Med Assoc; 1990 Nov; 89(11):977-81. PubMed ID: 1982130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing complement-mediated opsonic activity of rabbit interstitial fluids from autologous serum.
    Lam C; Georgopoulos A; Schütze E
    Comp Immunol Microbiol Infect Dis; 1988; 11(1):1-9. PubMed ID: 3289826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Giebink GS; Verhoef J; Peterson PK; Quie PG
    Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic activity and composition of five intramuscular gammaglobulin preparations.
    van Furth R; Braat AG; Leijh PC; Klein F
    J Infect; 1986 Nov; 13(3):269-75. PubMed ID: 2432132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency.
    Simberkoff MS; Moldover NH; Rahal J
    J Lab Clin Med; 1980 Mar; 95(3):362-72. PubMed ID: 6986445
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
    Barrio MB; Rainard P; Gilbert FB; Poutrel B
    J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.
    Peterson PK; Verhoef J; Sabath LD; Quie PG
    Infect Immun; 1976 Aug; 14(2):496-501. PubMed ID: 971959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis.
    Zwahlen A; Nydegger UE; Vaudaux P; Lambert PH; Waldvogel FA
    J Infect Dis; 1982 May; 145(5):635-46. PubMed ID: 7077088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.
    Hof DG; Repine JE; Peterson PK; Hoidal JR
    Am Rev Respir Dis; 1980 Jan; 121(1):65-71. PubMed ID: 7352714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes.
    Hoidal JR; Schmeling D; Peterson PK
    J Infect Dis; 1981 Jul; 144(1):61-71. PubMed ID: 7021701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients.
    Keusch GT; Ambinder EP; Kovacs I; Goldberg JD; Phillips DM; Holland JF
    Am J Med; 1982 Oct; 73(4):552-63. PubMed ID: 6751084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.
    Xu S; Arbeit RD; Lee JC
    Infect Immun; 1992 Apr; 60(4):1358-62. PubMed ID: 1548061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.
    Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG
    Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.